Skip to content
Insider tapeFilings through Fri, Oct 2
COO

Cooper Companies (The) insider trading

Health Care · Strong buying
Close · Oct 5, 2026 $56.77 -19.0% over 12 months

Share price and insider trades

COO closeInsider buyInsider sale
5060708090NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $82,130 on 2025-12-18 · Maria RivasBought $149,963 on 2025-12-22 · Cynthia L LuccheseBought $165,000 on 2025-12-17 · Lawrence Erik KurziusBought $549,320 on 2026-09-16 · Lawrence Erik KurziusBought $628,770 on 2026-09-11 · Paul A Keel, Walter M Rosebrough Jr.Bought $702,020 on 2026-09-14 · Lawrence Erik Kurzius, Walter M Rosebrough Jr.Bought $907,322 on 2025-12-16 · Albert G White III, Holly R Sheffield
Bought, 12 months$3.2M
Sold, 12 months$0
Insiders buying7
Insiders selling0

Valuation, profit and volume

Pick score 69/100
P/E (trailing)19.5Sector median 24.5
Market value$10.80BMedical Instruments & Supplies
Profit margin13.5%Revenue growth +0.6%
Volume vs. 50-day1.4×Last 5 sessions
Insiders' paper profit−$305KOn all tracked purchases -9.6%

Summary

Over the past 12 months, 7 Cooper Companies (The) insiders reported open-market purchases totaling $3.2M, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Sep 11, 2026, when 3 insiders bought a combined $1.9M.

News and SEC events

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales. 36 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Sep 17SEC Lawrence Erik KurziusDirector Buy 10,000 $54.93 $549K +3.3% —
Sep 15SEC Lawrence Erik KurziusDirector Buy 10,000 $53.91 $539K +5.3% —
Sep 15SEC Walter M Rosebrough Jr.Director Buy 7,000 $54.11 $379K +4.9% —
Sep 15SEC Paul A KeelDirector Buy 4,701 $53.18 $250K +6.8% —
Sep 15SEC Walter M Rosebrough Jr.Director Buy 3,000 $54.29 $163K +4.6% —
Dec 23SEC Cynthia L LuccheseDirector Buy 1,784 $84.06 $150K -32.5% —
Dec 19SEC Maria RivasDirector Buy 1,000 $82.13 $82K -30.9% —
Dec 17SEC Lawrence Erik KurziusDirector Buy 2,000 $82.50 $165K -31.2% —
Dec 16SEC Albert G White IIICEO, President Buy 10,000 $80.80 $808K -29.7% —
Dec 16SEC Holly R SheffieldPresident Buy 1,230 $80.75 $99K -29.7% —

Insiders at Cooper Companies (The)

InsiderBoughtSoldLast filingScore
Lawrence Erik KurziusDirector $1.3M — Sep 17, 2026 —
Albert G White IIICEO, President $808K — Jan 12, 2026 —
Walter M Rosebrough Jr.Director $542K — Sep 15, 2026 —
Paul A KeelDirector $250K — Sep 15, 2026 —
Cynthia L LuccheseDirector $150K — Apr 6, 2026 —
Holly R SheffieldPresident $99K — Jan 12, 2026 —
Maria RivasDirector $82K — Apr 6, 2026 —
Teresa S MaddenDirector — — Apr 6, 2026 —
Robert S WeissDirector — — Apr 6, 2026 —
Colleen JayDirector — — Apr 6, 2026 —
Barbara CarboneDirector — — Apr 6, 2026 —
Daniel G McbrideCOO — — Jan 12, 2026 —
Brian G AndrewsCFO — — Jan 12, 2026 —
Gerard H Warner IIIPresident — — Jan 12, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • BSXBoston Scientific$9.5M bought
  • PFEPfizer$3.0M bought
  • ELVElevance Health$1.4M bought
  • PODDInsulet Corporation$162K bought
  • SYKStryker Corporation$27K bought
  • CRLCharles River Laboratories$3K bought

Common questions about COO insiders

Are Cooper Companies (The) insiders buying COO stock?

In the past 12 months, 7 insiders reported open-market purchases of COO worth $3.2M. The latest was Director Lawrence Erik Kurzius bought $549K of COO at $54.93 — raises the stake by 47%.

Are Cooper Companies (The) insiders selling COO stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.